Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-28
DOI
10.3389/fendo.2019.00325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical outcomes of frozen embryo versus fresh embryo transfer following in vitro fertilization: a meta-analysis of randomized controlled trials
- (2018) Wanlin Zhang et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012–2013
- (2018) Reshef Tal et al. FERTILITY AND STERILITY
- Very low anti-müllerian hormone concentrations are not an independent predictor of embryo quality and pregnancy rate
- (2018) Alberto Pacheco et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
- (2017) Anders Nyboe Andersen et al. FERTILITY AND STERILITY
- New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF
- (2017) Nathalie Massin HUMAN REPRODUCTION UPDATE
- Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women
- (2017) Haiyan Zheng et al. MEDICINE
- Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
- (2017) Qiuju Chen et al. Reproductive Biology and Endocrinology
- A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles
- (2017) Adolfo Allegra et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
- (2017) Haiyan Guo et al. Scientific Reports
- Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol
- (2016) Huiyu Xu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist
- (2016) Xuefeng Lu et al. FERTILITY AND STERILITY
- Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF
- (2016) Yun Wang et al. MEDICINE
- Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study
- (2016) Rong Li et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
- (2015) Yanping Kuang et al. FERTILITY AND STERILITY
- Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis
- (2015) Reshef Tal et al. FERTILITY AND STERILITY
- Testing and interpreting measures of ovarian reserve: a committee opinion
- (2015) FERTILITY AND STERILITY
- Assessing ovarian response: antral follicle count versus anti-Müllerian hormone
- (2015) Richard Fleming et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles
- (2014) David E. Reichman et al. FERTILITY AND STERILITY
- Female age-related fertility decline
- (2014) FERTILITY AND STERILITY
- Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone
- (2014) O. Hamdine et al. HUMAN REPRODUCTION
- The physiology and clinical utility of anti-Müllerian hormone in women
- (2014) Didier Dewailly et al. HUMAN REPRODUCTION UPDATE
- Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
- (2014) Simone L. Broer et al. HUMAN REPRODUCTION UPDATE
- Ovarian Response and Cumulative Live Birth Rate of Women Undergoing In-Vitro Fertilisation Who Had Discordant Anti-Mullerian Hormone and Antral Follicle Count Measurements: A Retrospective Study
- (2014) Hang Wun Raymond Li et al. PLoS One
- Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study
- (2013) Nikolaos P. Polyzos et al. FERTILITY AND STERILITY
- Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis
- (2013) Simone L. Broer et al. FERTILITY AND STERILITY
- Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients
- (2013) Joan-Carles Arce et al. FERTILITY AND STERILITY
- Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women
- (2013) Maria E. Bleil et al. FERTILITY AND STERILITY
- Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
- (2013) A. La Marca et al. HUMAN REPRODUCTION UPDATE
- Antimüllerian Hormone Levels Are Strongly Associated With Live-Birth Rates After Assisted Reproduction
- (2013) Thomas Brodin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles
- (2013) Alon Kedem et al. PLoS One
- Possibilities and Limits of Ovarian Reserve Testing in ART
- (2012) Antonio La Marca et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
- (2012) E. Anckaert et al. HUMAN REPRODUCTION
- Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
- (2012) Simone L. Broer et al. HUMAN REPRODUCTION UPDATE
- Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF
- (2011) A. P. Yates et al. HUMAN REPRODUCTION
- ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
- (2011) A. P. Ferraretti et al. HUMAN REPRODUCTION
- The journey from the old to the new AMH assay: how to avoid getting lost in the values
- (2011) S.M. Nelson et al. REPRODUCTIVE BIOMEDICINE ONLINE
- AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
- (2010) S. L. Broer et al. HUMAN REPRODUCTION UPDATE
- Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
- (2009) S. M. Nelson et al. HUMAN REPRODUCTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started